A carregar...

Targeting SOD1 reduces experimental non–small-cell lung cancer

Approximately 85% of lung cancers are non–small-cell lung cancers (NSCLCs), which are often diagnosed at an advanced stage and associated with poor prognosis. Currently, there are very few therapies available for NSCLCs due to the recalcitrant nature of this cancer. Mutations that activate the small...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Glasauer, Andrea, Sena, Laura A., Diebold, Lauren P., Mazar, Andrew P., Chandel, Navdeep S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871252/
https://ncbi.nlm.nih.gov/pubmed/24292713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI71714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!